Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_provenance.
- NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_assertion description "[Clinically, 11q23 patients had acute lymphoblastic leukemia (ALL) more often as their primary disease and a shorter latency from start of treatment for the primary disease to their t-MDS/t-AL diagnosis, except when compared with the inv(16) subgroup.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_provenance.
- NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_assertion evidence source_evidence_literature NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_provenance.
- NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_assertion SIO_000772 11921271 NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_provenance.
- NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_assertion wasDerivedFrom befree-2016 NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_provenance.
- NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_assertion wasGeneratedBy ECO_0000203 NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_provenance.
- befree-2016 importedOn "2016-02-19" NP350093.RAC7x5UeFx_Vt3jJAkvsPsdO1aXCzlZC5hi2R_y9k9fu8130_provenance.